LGALS3 and liver cancer: Analysis of LGALS3 expression patterns in human MASLD and liver cancer datasets (GSE135251, GSE126848, GSE124535, GSE130970 and The Cancer Genome Atlas Liver Hepatocellular Carcinoma) [38–41] revealed a significant up-regulation of LGALS3 levels in MASH compared to healthy or MASLD tissues.